Dave A. Miller

发表

M. Gil, Dave A. Miller, 2012 .

Alan B. Watts, Dave A. Miller, R. Williams, 2012, AAPS Advances in the Pharmaceutical Sciences Series.

Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing

Daniel A. Davis, A. Nokhodchi, Dave A. Miller, 2020, AAPS PharmSciTech.

Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity

Daniel A. Davis, Dave A. Miller, R. Williams, 2021, International journal of pharmaceutics: X.

Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.

Dave A. Miller, R. Williams, J. Mcginity, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

KinetiSol: A new processing paradigm for amorphous solid dispersion systems

Dave A. Miller, R. Williams, J. Mcginity, 2012 .

KinetiSol®-Based Amorphous Solid Dispersions

Dave A. Miller, J. Keen, 2014 .

Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.

Leena Kumari Prasad, Dave A. Miller, R. Williams, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs

Dave A. Miller, J. Mcginity, J. Hughey, 2017, AAPS PharmSciTech.

Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing

Dave A. Miller, R. Williams, Daniel J Ellenberger, 2018, AAPS PharmSciTech.

Editorial for Theme Issue: Applications of KinetiSol Dispersing for Advanced Amorphous Solid Dispersions

Dave A. Miller, 2018, AAPS PharmSciTech.

Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet

Dave A. Miller, R. Williams, Daniel J Ellenberger, 2018, AAPS PharmSciTech.

Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review

Dave A. Miller, R. Williams, Daniel J Ellenberger, 2018, AAPS PharmSciTech.

Homogeneity of amorphous solid dispersions – an example with KinetiSol®

Dave A. Miller, R. Williams, Yongchao Su, 2019, Drug development and industrial pharmacy.

Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities

Daniel A. Davis, Dave A. Miller, R. Williams, 2020, AAPS PharmSciTech.

In vitro and in vivo behavior of KinetiSol® and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer.

Dave A. Miller, R. Williams, Yongchao Su, 2020, Molecular pharmaceutics.

Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions

Dave A. Miller, R. Williams, Urvi Gala, 2020, Pharmaceutics.

Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.

Dave A. Miller, R. Williams, J. Mcginity, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.

K. Johnston, Wei Yang, Dave A. Miller, 2008, International journal of pharmaceutics.

Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.

N. Clemens, Dave A. Miller, R. Williams, 2007, International journal of pharmaceutics.

The Effect of Drug Loading on the Properties of Abiraterone-Hydroxypropyl Beta Cyclodextrin Solid Dispersions Processed by Solvent Free KinetiSol® Technology.

Dave A. Miller, Yongchao Su, Angela Spangenberg, 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing

Dave A. Miller, J. Mcginity, James C Dinunzio, 2010, Drug development and industrial pharmacy.

Advanced Formulation Design: Improving Drug Therapies for the Management of Severe and Chronic Pain

Dave A. Miller, R. Williams, James C Dinunzio, 2008, Drug development and industrial pharmacy.

Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.

Wei Yang, Dave A. Miller, R. Williams, 2008, Molecular pharmaceutics.

Hot-melt extrusion for enhanced delivery of drug particles.

Wei Yang, Dave A. Miller, R. Williams, 2007, Journal of pharmaceutical sciences.

Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.

James W McGinity, Dave A. Miller, R. Williams, 2010, Journal of pharmaceutical sciences.

Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)

Dave A. Miller, R. Williams, Chris Brough, 2016, AAPS PharmSciTech.

Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1)

Dave A. Miller, R. Williams, Chris Brough, 2016, AAPS PharmSciTech.

Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.

Nicholas A Peppas, James W McGinity, N. Peppas, 2008, International journal of pharmaceutics.

Mucoadhesive amorphous solid dispersions for sustained release of poorly water soluble drugs

Leena Kumari Prasad, Dave A. Miller, R. Williams, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions

Leena Kumari Prasad, Dave A. Miller, R. Williams, 2016, AAPS PharmSciTech.

Targeted Intestinal Delivery of Supersaturated Itraconazole for Improved Oral Absorption

Wei Yang, Dave A. Miller, R. Williams, 2008, Pharmaceutical Research.

Enhanced In Vivo Absorption of Itraconazole via Stabilization of Supersaturation Following Acidic-to-Neutral pH Transition

Wei Yang, Dave A. Miller, R. Williams, 2008 .

Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition.

James W McGinity, Wei Yang, Dave A. Miller, 2008, Drug development and industrial pharmacy.

Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.

K. Johnston, Dave A. Miller, R. Williams, 2007, International journal of pharmaceutics.

Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review

Dave A. Miller, R. Williams, Daniel J. Ellenberger, 2018, AAPS PharmSciTech.

Formulating Poorly Water Soluble Drugs

Alan B. Watts, Dave A. Miller, R. Williams, 2016, AAPS Advances in the Pharmaceutical Sciences Series.

Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir

Dave A. Miller, J. Mcginity, Chris Brough, 2016, The Journal of pharmacy and pharmacology.

Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions.

Dave A. Miller, R. Williams, Urvi Gala, 2020, Biochimica et biophysica acta. Reviews on cancer.

Aqueous Polymeric Film Coating

Dave A. Miller, J. Mcginity, 2008 .

The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.

Dave A. Miller, J. Mcginity, J. Hughey, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions

Leena Kumari Prasad, Dave A. Miller, R. Williams, 2016, AAPS PharmSciTech.

Dissolution Enhancement of a Drug Exhibiting Thermal and Acidic Decomposition Characteristics by Fusion Processing: A Comparative Study of Hot Melt Extrusion and KinetiSol® Dispersing

Dave A. Miller, Chris Brough, J. Hughey, 2010, AAPS PharmSciTech.

Minimization of Acid-Catalyzed Degradation in KinetiSol Processing through HPMCAS Neutralization.

Dave A. Miller, Sandra U. Kucera, Angela Spangenberg, 2023, Molecular pharmaceutics.

Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract

Dave A. Miller, R. Williams, J. Mcginity, 2015, Drug development and industrial pharmacy.

Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier.

James W McGinity, Dave A. Miller, J. Mcginity, 2012, International journal of pharmaceutics.

Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet

Dave A. Miller, R. Williams, Sandra U. Kucera, 2018, AAPS PharmSciTech.

Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison

Daniel A. Davis, Dave A. Miller, Sandra U. Kucera, 2023, AAPS PharmSciTech.

Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution

Daniel A. Davis, Dave A. Miller, Sandra U. Kucera, 2023, Biomedicines.

Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing

Dave A. Miller, J. Mcginity, James C Dinunzio, 2010, Drug development and industrial pharmacy.